Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-19
DOI
10.1038/s41467-021-22033-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles
- (2019) Angelica Ortiz et al. CANCER CELL
- STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion
- (2019) Chuan-xia Zhang et al. CELL DEATH AND DIFFERENTIATION
- Melanoma extracellular vesicles generate immunosuppressive myeloid cells by PD-L1 upregulation via TLR4 signaling
- (2019) Viktor Fleming et al. CANCER RESEARCH
- Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
- (2019) Philipp Metzger et al. Journal for ImmunoTherapy of Cancer
- Plasticity of myeloid-derived suppressor cells in cancer
- (2018) Evgenii Tcyganov et al. CURRENT OPINION IN IMMUNOLOGY
- IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells
- (2018) Wei Xiao et al. JOURNAL OF IMMUNOLOGY
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Unique pattern of neutrophil migration and function during tumor progression
- (2018) Sima Patel et al. NATURE IMMUNOLOGY
- IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections
- (2018) Kelly M. Shepardson et al. Frontiers in Immunology
- Immunosuppressive Myeloid Cells’ Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy
- (2017) Neha Kamran et al. MOLECULAR THERAPY
- Effective combinatorial immunotherapy for castration-resistant prostate cancer
- (2017) Xin Lu et al. NATURE
- Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
- (2017) Hua Liang et al. Nature Communications
- Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
- (2017) Guoliang Yang et al. Oncotarget
- Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
- (2017) Yago Pico de Coana et al. Oncotarget
- Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
- (2016) Sung-Eun Lee et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
- (2016) M. Sade-Feldman et al. CLINICAL CANCER RESEARCH
- Chronic Type I IFN Is Sufficient To Promote Immunosuppression through Accumulation of Myeloid-Derived Suppressor Cells
- (2016) Kahina Taleb et al. JOURNAL OF IMMUNOLOGY
- Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent
- (2016) Trevor E. Angell et al. THYROID
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
- (2016) Yuliya V. Katlinskaya et al. Cell Reports
- Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
- (2016) J. Weber et al. Cancer Immunology Research
- Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients
- (2016) K. Tada et al. Cancer Immunology Research
- The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis
- (2016) Shuo Zhang et al. PLoS One
- Innate Immune Recognition of Cancer
- (2015) Seng-Ryong Woo et al. Annual Review of Immunology
- Transcriptional regulation of myeloid-derived suppressor cells
- (2015) Thomas Condamine et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The molecular basis for functional plasticity in type I interferon signaling
- (2015) Gideon Schreiber et al. TRENDS IN IMMUNOLOGY
- The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
- (2015) Mahiru Kawano et al. Scientific Reports
- Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
- (2015) F. Hossain et al. Cancer Immunology Research
- Trial Watch—Immunostimulation with cytokines in cancer therapy
- (2015) Erika Vacchelli et al. OncoImmunology
- IL-6-stimulated CD11b+ CD14+ HLA-DR− myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus
- (2015) Miao-Fen Chen et al. Oncotarget
- Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy
- (2014) Alessandra Romano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury
- (2014) S. Bhattacharya et al. EMBO Molecular Medicine
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors
- (2014) Paul T. Thevenot et al. IMMUNITY
- ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis
- (2014) Thomas Condamine et al. JOURNAL OF CLINICAL INVESTIGATION
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- Pathogenic potential of interferon αβ in acute influenza infection
- (2014) Sophia Davidson et al. Nature Communications
- Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
- (2013) Ang Huang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts
- (2013) Sarah K. Maenhout et al. INTERNATIONAL JOURNAL OF CANCER
- STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
- (2013) David Vasquez-Dunddel et al. JOURNAL OF CLINICAL INVESTIGATION
- Hope and Fear for Interferon: The Receptor-Centric Outlook on the Future of Interferon Therapy
- (2013) Serge Y. Fuchs JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1
- (2013) Nicole A de Weerd et al. NATURE IMMUNOLOGY
- Type I and Type III Interferons Drive Redundant Amplification Loops to Induce a Transcriptional Signature in Influenza-Infected Airway Epithelia
- (2013) Stefania Crotta et al. PLoS Pathogens
- Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
- (2012) Y. Shirota et al. JOURNAL OF IMMUNOLOGY
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses
- (2012) S Bhattacharya et al. ONCOGENE
- Matrix Metalloproteinase-2 Conditions Human Dendritic Cells to Prime Inflammatory TH2 Cells via an IL-12- and OX40L-Dependent Pathway
- (2011) Emmanuelle Godefroy et al. CANCER CELL
- CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2011) C. Zoglmeier et al. CLINICAL CANCER RESEARCH
- In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site
- (2011) Jessica M. Haverkamp et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2
- (2011) Laura Icardi et al. FASEB JOURNAL
- Role of p38 Protein Kinase in the Ligand-independent Ubiquitination and Down-regulation of the IFNAR1 Chain of Type I Interferon Receptor
- (2011) Sabyasachi Bhattacharya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
- (2011) Je-In Youn et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Inflammatory signaling compromises cell responses to interferon alpha
- (2011) W-C HuangFu et al. ONCOGENE
- Type I Interferon Signaling Regulates Ly6Chi Monocytes and Neutrophils during Acute Viral Pneumonia in Mice
- (2011) Sang-Uk Seo et al. PLoS Pathogens
- Type I Interferons Regulate Cytolytic Activity of Memory CD8+ T Cells in the Lung Airways during Respiratory Virus Challenge
- (2010) Jacob E. Kohlmeier et al. IMMUNITY
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon: friend or foe?
- (2010) Giorgio Trinchieri JOURNAL OF EXPERIMENTAL MEDICINE
- Temporal and Spatial Resolution of Type I and III Interferon Responses In Vivo
- (2010) J. E. Pulverer et al. JOURNAL OF VIROLOGY
- Ligand-Stimulated Downregulation of the Alpha Interferon Receptor: Role of Protein Kinase D2
- (2010) H. Zheng et al. MOLECULAR AND CELLULAR BIOLOGY
- Inducible Priming Phosphorylation Promotes Ligand-independent Degradation of the IFNAR1 Chain of Type I Interferon Receptor
- (2009) Sabyasachi Bhattacharya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Induction of myeloid-derived suppressor cells by tumor exosomes
- (2008) Xiaoyu Xiang et al. INTERNATIONAL JOURNAL OF CANCER
- Interferon-λ Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic Viruses
- (2008) Markus Mordstein et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now